Details
Category: Volume 12 Issue 03 March 2024
Hits: 101

Title: Sexual Dysfunction with Risperidone in Male and Female Patients of Schizophrenia

Authors: Dr Malleeka Bora, M.D., Dr Soumitra Ghosh, M.D.

 DOI: https://dx.doi.org/10.18535/jmscr/v12i03.13

Abstract

Background:  Sexual side-effects due to use of Antipsychotic drugs have become one of the most important determinants of treatment compliance.  Studies regarding sexual side-effects associated with antipsychotics comprise only a handful in the Indian population, especially so in this north-eastern part of the country.

Aims and Objectives

  1. To assess the sexual dysfunction associated with Risperidone in male and female patients of Schizophrenia.
  2. To compare the sexual dysfunction associated with Risperidone between male and female patients of Schizophrenia.

Materials and Methods: This was a hospital based comparative study conducted on 50 clinically stable male and female patients of Schizophrenia on Risperidone only. A Sexual Functioning Questionnaire (SFQ) was administered after assessing the clinical stabilities with the Brief Psychiatric Rating Scale (BPRS). Sexual dysfunction was assessed by calculating the mean scores on all the domains of sexual functioning in SFQ which were then compared across the study groups using the Chi square test . The results were analysed using SPSS Version 16.0 setting the significance threshold at p <0.05.

Results: From this study, we inferred that with Risperidone, impairment is seen in desire disorders (12%), arousal disorders (14%), orgasmic difficulties (26%) and overall sexual dysfunction (20%) although not statistically significant. It was also found that in females, Risperidone caused more desire disorders, more arousal disorders and a more overall sexual dysfunction; whereas in case of males, Risperidone caused more arousal disorders, more orgasmic difficulties, more sex related pain problems and a more overall sexual dysfunction;

Conclusion: Sexual dysfunction is an important side-effect of Antipsychotic drugs. So clinicians should try to address these side-effects to help patients’ attain a better compliance.

References

  1. Infrasca R; Sexual Dysfunction Questionnaire: scale development and psychometric validation; Giorn Ital Psicopat; 2011;17:253-260.
  2. Aizenberg D, Zemishlany Z, Dolfman-Etrog P, Weizman A; Sexual dysfunction in male schizophrenic patients; J Clin Psychiatry; 1995;56:137-141.
  3. Malik P, Kemmler G, Hummer M, et al.; Sexual dysfunction in first-episode schizophrenia patients- Results from European first episode schizophrenia trial.; J Clin Psychopharmacol. ; 2011;31:274–280.
  4. Fujii A, Yasui-Furukori N, Sugawara N, et al.; Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics.; Prog Neuropsychopharmacol Biol Psychiatry.; 2010;34:288–293.
  5. The ICD-10 Classification of Mental and Behavioral Disorders-Clinical descriptions and diagnostic guidelines. World Health Organization, Geneva, A.I.T.B.S Publishers & Distributors, 2007
  6. Baggaley M.; Sexual dysfunction in schizophrenia: focus on recent evidence.; Hum Psychopharmacol.; 2008;23:201–209.
  7. Knegtering R, Casrelein A, Bous H, Van Der Linsle I. ; A randomized open label study of impact of quetiapine versus risperidone on sexual functioning.; J Clin Psychopharmacol ;2004;24(1):56-61.
  8. Knegtring H, Van den Bosch R, Castelein S, Bruggeman R, Sytema S et al. ; Are sexual side effects of prolactin-rising antipsychotics reducible to serum prolactin?; ; 2008 Jul;33(6):111-7.
  9. Knegtering H, van der Moolen AE, Castelein S, Kluiter H, van den Bosch RJ.; What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? ; Psychoneuroendocrinology.; 2003;28(suppl 2):109–123. .
  10. Knegtering H, Boks M, Blijd C, Castelein S, van den Bosch RJ, Wiersma D. A ; Randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning.; J Sex Marital Ther. ; 2006;32:315–326.
  11. de Boer MK, Wiersma D, Bous J, ; A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study).; J Clin Psychopharmacol.; 2011;31:523–525.
  12. Sadock BJ, Sadock VA, Ruiz P; Psychiatric Rating Scales; Synopsis of Psychiatry; 10th edition; Lippincott Williams and Wilkins; 2007; 1093-1094.
  13. Weiden PJ, Miller AL; Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications; J Psychiatr Pract; 2001, 7:41-47.
  14. Finn SE, Bailey JM, Schultz RT, Faber R. ; Subjective utility ratings of neuroleptics in treating schizophrenia;. Psychol Med.; 1990;20:843–848.
  15. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M and Treuer T ; Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.; European Psychiatry 21,; 2006, 4, 251-258.
  16. Serretti A, Chiesa A.; A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics.; Int Clin Psychopharmacol.; 2011;26:130–140.
  17. Ghadirian AM, Chouinard G, Annable L ; Sexual dysfunction and prolactin levels in neuroleptic treated Schizophrenic outpatients; J Nerv Ment Dis ; 1982;170:463-467.
  18. Donnellan P, Breathnach O, Crown JP. ; Odynorgasmia. ; Scand J Urol Nephrol. 2001;35:158.
  19. Fitzgerald P, Dinan TG. ; Prolactin and dopamine: What is the connection? A review article.; Psychopharmacol. ;22; 2008; 12-19.
  20. Segraves RT.; Effects of psychotropic drugs on human erection and ejaculation.; Arch Gen Psychiatry ;1989;46:275-84.
  21. Konarzewska B, Szulc A, Poptawska R, Galinska B, Juchnowicz D.; Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients.; Psychiatr Pol. ; 2008;42(1):87-95.
  22. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbaner H, Fleishhacker WW; Sexual disturbances during clozapine and haloperidol treatment for schizophrenia; Am J Psychiatry ; 1999;156:631-633.
  23. Burke MA, McEvoy JP, Ritchie JC; A pilot study of a structured interview addressing sexual function in men with Schizophrenia; Biol Psychiatry; 1994;35:32-35.
  24. Bobes J, Gare A, Portilla MP, Rejas J et al. ;Frequency of sexual dysfunction and other reproductive side-effects in patients with Schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.; J Sex Marital Ther ;2003;29(2):125-47. 
  25. Kotin J, Wilbert DE, Verburg D, Soldinger SM; Thioridazine and sexual dysfunction; Am J Psychiatry; 1976;133:82-85.
  26. Nagaraj AK, Pai NB, Rao S; A comparative study of sexual dysfunc­tion involving resperidone, quetiapine, and olanzapine.; Indian J Psychiatry; 2009; 51: 265-271.
  27. de Boer M. K. ; Antipsychotic treatment and sexual functioning: From mechanisms to clinical practice ; 2014; 7-161.
  28. Fortier P,Trudel G, Mottard JP et al; The influence of schizophrenia and standard or atypical neuroleptics on sexual and sociosexual functioning-a review; Sexuality and Disability; 2000;18(1); 85-104.
  29. Berger SH.; Trifluoperazine and haloperidol: sources of ejaculatory pain?; Am J Psychiatry.; 1979;136:350.
  30. Dickson RA, Glazer WM.; Neuroleptic induced hyperprolactinemia.; Schizophr Res.; 1999;35:75-86.
  31. Smith SM.; The impact of hyperprolactinemia on sexual function in patients with psychosis.; J Psychopharmacol;. 2008 Mar;22(2 suppl):63-9.

Corresponding Author

Dr Malleeka Bora, M.D.

Consultant Psychiatrist, Guwahati

Department of Psychiatry, Assam Medical College and Hospital (AMCH), Dibrugarh, Assam